BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues increased 7% to $516 million during the first quarter ended March 31, 2007, compared to $484 million in the first quarter of 2006. Reported net income equaled $116 million and diluted income per share equaled $0.48 during the first quarter of 2007, compared to net earnings of $51 million and diluted earnings per share of $0.21 in the fourth quarter of the prior year. Excluding special items, net earnings equaled $118 million and diluted earnings per share equaled $0.48 during the first quarter ended March 31, 2007, compared to net earnings of $106 million and diluted earnings per share of $0.44 in the first quarter of 2006.
